论文信息 - An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International - 字舞流文

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Emilie Cornec-Le Gall | G. Capasso | R. Müller | R. Gansevoort | V. Tesar | D. Mekahli | O. Devuyst | A. Ong | E. Hoorn | R. Torra | J. Sayer | F. Schaefer | N. Knoers | T. Nijenhuis | S. Walsh | A. Servais | Y. Meur | H. Birn | A. V. van Eerde | A. L. Messchendorp | T. Harris | Patrick Guirchon | U. Korst | E. Gall | Tom Nijenhuis